The Affordable Insulin Now Act (hr6833-117) caps out-of-pocket costs for insulin at $35 monthly under private insurance and Medicare, regulating the Pharmaceuticals & Biotech industry. Rep. Angie Craig (D-MN) introduced this bill. Pharmaceuticals & Biotech comprises 2.8% of Craig's identifiable donor base ($0.47M), ranking 50th among 253 industries within her party.

FOLLOW THE TRAIL
◈ Ask the Analyst about Angie Craig →How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated September 10, 2026 · internal signal score 47/100.